跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gentaxel-30 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gentaxel-30
Approved
STANDARD
Gentaxel-30
Venus Remedies Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
38d7a84aabcd91b2
Company
Venus Remedies Limited
Type
Standard
Approval Details
Approval Id
38d7a84aabcd91b2
Drug Approval Philippines Name
Gentaxel-30
Product Name
Gentaxel-30
Registration Number
DRP-8582-01
Brand Name
Gentaxel-30
Generic Name
Paclitaxel
Dosage Form
Concentrate Solution for Infusion (I.V.)
Dosage Strength
6mg/Ml (30mg/5mL)
Manufacturer
Venus Remedies Limited
Importer
Medinova Pharmaceutical Inc.
Distributor
GA2 Pharmaceutical Inc.
Company Detail Path
/organization/venus-remedies-limited
Issuance Date
27 October 2024
Expiry Date
18 December 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
38d7a84aabcd91b2
Type
Standard
Back to Philippines FDA Approvals